At a glance
ClinicalIndex Comparison RecordN/ACompleted· 250 enrolled
Drug / intervention
FFDM +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT Trial) ADAPT-SCR: Recruitment Plan for Asymptomatic Women Undergoing Screening Mammography
In Brief
A clinical study evaluating FFDM and DBT for Breast Cancer and 2 related conditions. Completed, enrolled 250 participants across 2 sites.
Detailed Summary
The aim of this recruitment plan (ADAPT-SCR) is to collect image and other data on both digital breast tomosynthesis (DBT) and full-field digital mammography (FFDM) from asymptomatic women undergoing screening mammography.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Tumors, Breast, Cancer Screening
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 2014
Enrollment StartMay 2015
Primary CompletionJul 2017
TodayJul 2026
First PostedDec 3, 2014
Enrollment StartMay 1, 2015
Primary CompletionJul 7, 2017
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 11.6 years ago
Interventions
FFDMdevice
2D imaging of the breast using Full-Field Digital Mammography (FFDM) device
DBTdevice
3D imaging of the breast using Digital Breast Tomosynthesis (DBT) device